The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD-Reference-Cited by-同舟云学术

The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD

Published:2006-03 Issue:3 Volume:47 Page:385-395
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Landray Martin,Baigent Colin,Leaper Craig,Adu Dwomoa,Altmann Paul,Armitage Jane,Ball Simon,Baxter Alex,Blackwell Lisa,Cairns Hugh S.,Carr Sue,Collins Rory,Kourellias Karen,Rogerson Mary,Scoble John E.,Tomson Charles R.V.,Warwick Graham,Wheeler David C.

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease;Lancet,1994

2. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes;Cheung;Br J Clin Pharmacol,2004

3. Randomised placebo-controlled trial of cholesterol-lowering with simvastatin in 20,536 high-risk individuals;Lancet,2002

4. Clinical epidemiology of cardiovascular disease in chronic renal disease;Foley;Am J Kidney Dis,1998

5. Premature cardiovascular disease in chronic renal failure;Baigent;Lancet,2000

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid lowering for prevention of venous thromboembolism: a network meta-analysis;European Heart Journal;2024-06-14

2. Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap;Nephrology;2024-04-29

3. Special Populations;Clinical Lipidology;2024

4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

5. Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?;Expert Opinion on Therapeutic Targets;2022-11-02